OncoSec Medical Inc (ONCSQ)

[chickpea598]

OncoSec approached REV·1 Engineering with a need for a new Electroporation & Genetic Payload Delivery device to reach internal cancerous tumors that could not be reached with their skin-based device.
REV·1 developed multiple design solutions addressing how to access the tumors, stabilize them, and deliver OncoSec's proprietary Genetic Payload, followed by electroporating the tumors.
REV·1 designed a simple hand-held unit that can be introduced in a minimally invasive out-patient setting to access tumors deep in the body. Currently in pre-clinical trials, this device, combined with OncoSec's proprietary gene therapy, will radically change the treatment of these deep-in-the-body, life-threatening tumors.

If we report positive results this fall in the combo study, I think it will be very interesting to see the next phase of development regarding the new electroporation device for deep solid tumors. The commercial implications for this device which can be used in an out-patient setting would be huge.